Heat Biologics Inc (NASDAQ:HTBX)
The 4 analysts offering 12-month price forecasts
for Heat Biologics Inc have a median target of 28.50, with a high
estimate of 35.00 and a low estimate of 20.00. The median estimate
represents a +314.24% increase from the last price of 6.88. 
 |
52 week highest 30.10
52 WEEKS LOW 1.36
| ID | Field1 | PRICES | UP | DOWN | REASON | DATE | TIME | News | type | Field2 |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 | HTsBX | $7.93 | 1/25/2021 | 12:24:00 PM | HTBX WAS UP ON PREMARKET UP TIL 8.25 | Immunotherapies Tcell mediated immuine sy |
No comments:
Post a Comment